GE HealthCare Technologies Inc. (GEHCV) Stock Overview
Explore GE HealthCare Technologies Inc.’s financial performance, market position, analyst ratings, and future outlook.
GE HealthCare Technologies Inc. (GEHCV)
Key Financials
Key Financials
Market Cap
25.5B
P/E Ratio
13.40
EPS (TTM)
N/A
ROE
0.19%
GEHCV Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of GE HealthCare Technologies Inc. (NASDAQ: GEHCV) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, GE HealthCare Technologies Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of GEHCV on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $56.00 for the NASDAQ listing.
Key metrics behind GE HealthCare Technologies Inc.'s NASDAQ-traded stock include a P/E ratio of 13.40 and a market capitalization of 25.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of GEHCV on the NASDAQ.